Yahoo
Shenzhen - Delayed Quote CNY

Zhejiang NHU Company Ltd. (002001.SZ)

25.60 +0.16 (+0.63%)
At close: October 30 at 3:04:48 PM GMT+8
Chart Range Bar
Loading chart for 002001.SZ
  • Previous Close 25.44
  • Open 24.80
  • Bid 25.62 x --
  • Ask 25.63 x --
  • Day's Range 25.03 - 25.91
  • 52 Week Range 23.80 - 40.19
  • Volume 21,744,563
  • Avg. Volume 26,068,918
  • Market Cap (intraday) 78.68B
  • Beta (5Y Monthly) 0.23
  • PE Ratio (TTM) 10.76
  • EPS (TTM) 2.38
  • Earnings Date --
  • Forward Dividend & Yield 1.00 (3.91%)
  • 1y Target Est 32.34
  • Moby Rating Neutral

Zhejiang NHU Company Ltd., together with its subsidiaries, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through Pharmaceutical and Chemical; and Other segments. The company offers animal nutrition products comprising vitamins, amino acids, and carotenoids for poultry, swine, ruminants, and farmed fish; human nutrition products consisting of vitamins A, D3, E, H, C, B5, B6, and B12, as well as coenzyme Q10, beta carotene, taurine, and l-serine for use in nutritional supplements, food and beverages, and personal care applications; and flavor and fragrance products, including fruity, floral, and green/herbal products for use in soap, toothpaste, shampoo, skin care products, and food and beverage products. It also provides pigments; methionine, biotin, cysteine, and tryptophan; linalool, citral, leaf alcohol, methyl dihydrojasmonate, raspberry ketone, privet aldehyde, and menthol; PPS and PPA resins, PPS fibers, LTF composite materials, and PPS cast films and heat pipes; chemical products, such as prenol, l-ascorbic acid, acrylic acid, acrolein, sodium thiomethoxide in H2O, acrolein cyanohydrin acetate, diethyl oxalate/oxalic acid diethyl ester, potassium sulfate, ammonium sulfate, isophorone, cyclopentanone, and isovaleraldehyde for use in construction chemicals, crop protection, fertilizers, industrial solvents, and intermediates. In addition, the company offers active pharmaceutical ingredients, vitamins, and pharmaceutical intermediates, as well as professional services for preparation companies. The company exports its products. The company was incorporated in 1999 and is headquartered in Xinchang, the People's Republic of China. Zhejiang NHU Company Ltd. operates as a subsidiary of NHU Holding Group Co.,Ltd.

www.cnhu.com

11,508

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002001.SZ
4.35%
SSE Composite Index (000001.SS)
9.32%

1-Year Return

002001.SZ
8.22%
SSE Composite Index (000001.SS)
9.73%

3-Year Return

002001.SZ
74.09%
SSE Composite Index (000001.SS)
19.11%

5-Year Return

002001.SZ
32.21%
SSE Composite Index (000001.SS)
1.46%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 6.1B
Earnings 1.86B
Profit Margin 30.43%

Q3

FY25

Q4

FY25

Q1

FY26

Q3

FY26

0
2B
4B
6B
26.0%
27.0%
28.0%
29.0%
30.0%

Analyst Insights

View More

Analyst Price Targets

16.80 Low
32.34 Average
25.60 Current
41.70 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    29.43%

  • Return on Assets (ttm)

    11.12%

  • Return on Equity (ttm)

    21.27%

  • Revenue (ttm)

    24.84B

  • Net Income Avi to Common (ttm)

    7.31B

  • Diluted EPS (ttm)

    2.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.88B

  • Total Debt/Equity (mrq)

    20.53%

  • Levered Free Cash Flow (ttm)

    4.76B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: